SARS-CoV2 drives JAK1/2-dependent local and systemic complement hyperactivation

Patients with coronavirus disease 2019 (COVID-19) present with a range of devastating acute clinical manifestations affecting the lungs, liver, kidneys and gut. The best-characterized entry receptor for the disease-causing virus SARS-CoV2, angiotensin converting enzyme (ACE) 2, is highly expressed i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Bingyu, Freiwald, Tilo, Chauss, Daniel, Wang, Luopin, West, Erin, Bibby, Jack, Olson, Matthew, Kordasti, Shahram, Portilla, Didier, Laurence, Arian, Lionakis, Michail S, Kemper, Claudia, Afzali, Behdad, Kazemian, Majid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336704/
https://www.ncbi.nlm.nih.gov/pubmed/32702726
http://dx.doi.org/10.21203/rs.3.rs-33390/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336704/
https://www.ncbi.nlm.nih.gov/pubmed/32702726
http://dx.doi.org/10.21203/rs.3.rs-33390/v1

Ejemplares similares